Skip to content
Home/Companies/Biotech/Cellevate

Cellevate

Biotech·Sweden·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Cellevate?

Cellevate is currently owned by Almi Invest through Almi Invest (Regional funds) (2009 vintage), since 2026.

Hand-verified · updated 2026-08-18

Almi Invest
Investor
Almi Invest
Almi Invest (Regional funds) · 2009 · VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from Almi Invest (Regional funds)

Other portfolio companies in the same fund.

CubaseBio
Active
BiotechSweden· 2026
DAJE Prevent
Active
MedTechSweden· 2026
Permitify
Active
SaaSSweden· 2026
Radar Reticence
Active
SoftwareSweden· 2026
Rivus
Active
SoftwareSweden· 2026
Vascurie
Active
BiotechSweden· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
Track Cellevate

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Cellevate?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Cellevate.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue